Skip to content

Loading page…

Original disclosures,
open access.

Corporate sustainability reports for research and decisions.

Follow our research

Database

Sustainability reports
Countries
Exchanges
Sectors
Industries
Years
Statistics

Services

Reports
Packages
Solutions
Markdown
Enterprise licence
Coverage assurance
Download portal

About

About us
Clients
Research & news
Careers

Resources

Pricing
Questions & answers
API documentation
Contact
Become a Supporter

© 2026 SustainabilityReports.com. All rights reserved.

Privacy policy Terms of service

Biocon Ltd 2014 Annual Report with Sustainability Disclosures

Company: Biocon Ltd

Sector: Manufacturing

Country: India

Year: 2014

Type: Annual Report with Sustainability Disclosures

Pages: 196

Home
Biocon Ltd
2014 Annual Report with Sustainability Disclosures

Annual Report

Preview not available

Report overview

The report describes Biocon's FY14 launches of ALZUMAb and CANMAB, including affordable treatments for psoriasis and HER2-positive metastatic breast cancer. It records consolidated group revenue growth of 16% to INR 29,332 million. The sustainability section reports 30 tonnes of food waste composted and no recorded fatal accidents during the fiscal year.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2013-2014
Period: 1 April 2013 – 31 March 2014
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Assurance

Statement included

ESG & Materiality

ESG data

Indicators available in this report:

Energy consumption
Employees
Women on the board
Workplace fatalities

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown for your project.

Explore our services